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Abstract: Deuterated water (2H2O), a stable isotopic tracer, provides a convenient and reliable way
to label multiple cellular biomass components (macromolecules), thus permitting the calculation
of their synthesis rates. Here, we have combined 2H2O labelling, GC-MS analysis and a novel cell
fractionation method to extract multiple biomass components (DNA, protein and lipids) from the
one biological sample, thus permitting the simultaneous measurement of DNA (cell proliferation),
protein and lipid synthesis rates. We have used this approach to characterize the turnover rates and
metabolism of a panel of mammalian cells in vitro (muscle C2C12 and colon cancer cell lines). Our
data show that in actively-proliferating cells, biomass synthesis rates are strongly linked to the rate
of cell division. Furthermore, in both proliferating and non-proliferating cells, it is the lipid pool
that undergoes the most rapid turnover when compared to DNA and protein. Finally, our data in
human colon cancer cell lines reveal a marked heterogeneity in the reliance on the de novo lipogenic
pathway, with the cells being dependent on both ‘self-made’ and exogenously-derived fatty acid.
Keywords: deuterated water; biomass; GC-MS; stable isotopes; C2C12; colon cancer; protein
synthesis; lipogenesis; DNA synthesis
1. Introduction
The use of radioactive and stable isotope tracers to measure metabolic processes has underpinned
many fundamental discoveries in biochemistry and physiology [1]. Unlike ‘static’ measurements of
metabolite concentration, the use of tracers adds the dimension of time, allowing inferences to be
made about reaction rates and metabolic fluxes [1–3]. This kinetic feature permits the observation and
quantification of biochemical networks and biological processes, thus providing a detailed functional
readout of the behavior of the biological system [2,3]. In essence, metabolic pathway fluxes represent
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the functional output of multiple nonlinear regulatory layers that include gene, protein and metabolite
interactions [4].
To gain the most insight out of any experiment, it is ideal to be able to probe multiple pathways
simultaneously, thus allowing a broad assessment of cellular behavior. To do this, one would ideally
use a near-universal tracer that simultaneously labels multiple cellular metabolites (which can be
detected as free metabolites or constituents of macromolecules). In this regard, deuterated ‘heavy’
water (2H2O) is a particularly useful metabolic tracer [2,3]. Over 70 years ago, it was discovered
that introduction of low concentrations of 2H2O into biological systems results in the incorporation
of deuterium (2H) into a wide range of cellular metabolites and corresponding macromolecules
containing these metabolites [5–14]. Following the administration of 2H2O into the body water
pool in vivo or into cell culture media in vitro, 2H atoms become stably incorporated via enzyme
catalyzed reactions into C-H bonds of nonessential amino acids, glycerol-3-phosphate, fatty acids,
cholesterol, hexoses and pentoses (ribose and deoxyribose). Subsequent analysis of 2H labelling of these
constituents in macromolecules provides a highly sensitive measure of the rates of synthesis/turnover
of lipids [15–27], proteins [15,28–34], DNA [15,35,36], RNA [15] and glucose/glycogen [25,26,37–43]
and an objective assessment of fundamental cellular processes that include, but are not limited to,
rates of cell and organelle proliferation, cell and tissue biomass turnover, de novo lipogenesis and
gluconeogenesis. Such measurements have tremendous application to researchers in the field of cancer,
immunology, cardiovascular disease, metabolism, diabetes, obesity, developmental biology, as well
as the biotechnology and agricultural sectors. In addition to measuring multiple metabolic processes
simultaneously, 2H2O labelling is advantageous because: (1) the even distribution of the 2H2O in
the total body/cellular pool makes it simple to determine the precursor:product labelling ratios that
are required to calculate synthetic flux with confidence; (2) the 2H2O tracer can be easily and safely
administered for long periods of time in vivo and in vitro, permitting flux measurements in free living
conditions or long-term culture experiments; and (3) the capacity to label for extended periods of
time leads to efficient labelling of total cellular biomass, increasing the sensitivity of the analysis and
reducing artefacts that are sometimes associated with incomplete quenching of cells/tissues during
harvesting [3,24,32,35].
In most published studies, 2H2O labelling protocols generally focus on measuring 2H
incorporation into a single class of macromolecules, and/or replicate samples are prepared for
parallel extractions of different classes of macromolecules. However, the latter approach is not always
possible if sample is limiting. We therefore present here a simple method that simultaneously extracts
nucleic acid, protein, lipid and polar metabolite fractions from a single sample, enabling simultaneous
measurement of synthetic rates of different biomass components using 2H2O and gas chromatography
coupled to mass spectrometry (GC-MS). We have used this method to characterize cellular biomass
synthetic fluxes in a panel of mammalian cells in vitro, thus demonstrating the utility of this approach.
2. Methods
We have developed a method for sequentially extracting the major classes of macromolecules
from mammalian cells, although this method can be readily adapted to other eukaryotic cells that lack
a cell wall (Figure 1). We have found this method to be easily scalable depending on sample availability
and instrument sensitivity. The method is based on that described by Sapcariu et al. [44], but generates
a pellet containing protein and DNA/RNA after the initial organic solvent extraction, rather than an
interphase precipitate [44], facilitating the separation of protein/nucleic acid from polar and non-polar
metabolites. Furthermore, the method exploits a simple cell quenching protocol involving rapid
chilling of cultures/tissues on ice, which is sufficient to prevent the turnover of macromolecules of
interest during the initial extraction.
2.1. Cell Culture
The mouse C2C12 myoblast cell line was obtained from ATCC (Manassass, VA, USA). Human
cancer cell lines (colon carcinoma: DLD1, SW480, SKCO1 and LOVO) were obtained from ATCC
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and genetically validated at the Australian Genome Research Facility at the Walter and Eliza Hall
Institute of Medical Research. Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum
(FBS), horse serum, Dulbecco’s phosphate-buffered saline without calcium or magnesium (DPBS) and
cell trypsinizing agent TrypLE™ were from Life Technologies (ThermoFisher Scientific, Bayswater,
VIC, Australia). Corning tissue culture plastic-ware was purchased from In Vitro Technologies (Noble
Park, VIC, Australia). Deuterated water (deuterium oxide; 2H2O) was obtained from Sigma-Aldrich
(St. Louis, MO, USA). C2C12 myoblasts and colon carcinoma lines were cultured in 25 mM D-glucose
(high glucose, 4.5 g/L) DMEM containing glutamine, sodium pyruvate and HEPES (Life Technologies;
11995-073) supplemented with 10% v/v FBS (growth medium). All experiments were performed
on myoblasts cultured between Passages 4–10. To differentiate the myoblasts, cells were grown to
confluence, and the medium was changed to high glucose DMEM supplemented with 2% v/v horse
serum (differentiation medium). Growth and differentiation media were replenished every 48 h.
2.2. 2H2O Labelling
Experiment 1: C2C12 myoblasts were initially plated at 2 × 104 cells/mL in a 6-well plate in
duplicate before being suspended in growth medium containing 4% 2H2O and harvested at 12, 24,
48, 72, 96 and 120 h (with fresh 2H2O media replacement at the 48- and 96-h time-points). Note:
after reaching the 72 h time-point, the cells destined for the 96 and 120 h treatment were subcultured
(replated) at a lower density in the 4% 2H2O containing media in order to remain subconfluent and
hence in a proliferative state. Duplicate wells containing no cells were also filled with 4% 2H2O
labelled media and harvested at 96 h to provide extraction blank samples in order to determine if any
contamination was present (particularly with lipids). A parallel plate was also prepared in which
cells were incubated in standard growth media (non-2H2O) allowing for correction of natural isotopic
background abundance in the different macromolecular constituents. Experiment 1 was used to
initially establish the time course required to achieve plateau 2H enrichments in DNA and protein in
the C2C12 myoblasts, thus permitting the calculation of proliferation and protein turnover rates.
Experiment 2: An independent 2H2O labelling experiment was undertaken to assess the
reproducibility of the method and to detect fundamentally different biological behaviors in the same
cell type. Specifically, actively dividing C2C12 cells (proliferating myoblasts) and post-mitotic C2C12
cells that had been terminally differentiated into myotubes were labelled as described in Experiment
1 (although only including 12-, 24-, 48- and 96-h time-points). For labelling of the C2C12 myotubes,
myoblasts were plated as before; however, upon reaching confluence, myoblast cells were allowed to
differentiate for two days prior to the addition of 4% 2H2O differentiation medium to commence the
12–96-h labelling experiment. Macromolecular turnover was assessed by measuring 2H enrichment in
DNA-derived deoxyribose (proxy for cell proliferation rate), protein-derived alanine (proxy for protein
synthesis/turnover rates), total cellular palmitate (proxy for de novo lipogenesis) and lipid-derived
glycerol in the total lipid pool (proxy for membrane turnover).
Experiment 3: Triplicate wells were plated with DLD1, SW480, SKCO1 and LOVO cells
(1 × 104 cells/well) in DMEM with 10% FBS. Seventy-two hours post plating, 2H2O media (DMEM
with 5% 2H2O) were added over a time course of 8, 24, 48, 72 and 96 h with the same extraction blank
and ‘no labelling’ controls as described in Experiment 1.
2.3. Biomass Fractionation
The general workflow for this procedure is described and schematically depicted in Figure 1.
All solvents were analytical grade, and ultra-pure H2O was used. Culture plates were placed on
ice-water slurry and the media rapidly aspirated, prior to washing of the cell monolayers with ice
cold 0.154 M NaCl (0.9% w/v). Cells were subsequently covered in ice-cold methanol/H2O (1:1 v/v,
800 µL) then scraped and transferred to Eppendorf tubes. Protein and nucleic acids in the suspension
were precipitated by the addition of ice-cold isopropanol (400 µL) to generate a single phase solution
(methanol/H2O/isopropanol; ~1:1:1 v/v). At this stage, the samples were frozen at −80 ◦C (optional).
The suspension, containing flocculent material, was centrifuged for 10 min at 20,000× g and the clear
supernatant (containing polar and non-polar metabolites) transferred to a clean glass screw cap tube
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(100 × 13 mm Kimax® Test Tube). The single phase supernatant was converted to a two-phase system
by the addition of 400 µL chloroform. Following gentle centrifugation, the upper phase containing
polar metabolites was removed and discarded, while the bottom organic layer (isopropanol and
chloroform) was transferred to another clean glass tube and evaporated to complete dryness in a speed
vacuum (Labconco, Kansas, MO, USA) for analysis of total lipids. The presence of polar metabolites
in the upper phase of the cell supernatant was confirmed via GC-MS using previously published
methods [45,46] (Figure S1).
The first pellet fraction generated in the Eppendorf tube was gently washed by adding ice
cold methanol/H2O/isopropanol (1:1:1 v/v 600 µL) and centrifuged for 5 min at 20,000× g. The
supernatant was removed by gentle decanting and the pellet dried by leaving the tubes open in a fume
cupboard for 15–30 min; to ensure the supernatant is removed gently, as the pellet can be unstable.
After drying, the pellet was resuspended in ultra-pure H2O (50 µL), heated at 60 ◦C for 10 min followed
by thorough vortexing. Note: heating is required to resuspend the pellet, and this can be further
enhanced by immediate vortexing and or pipette mixing. The larger the pellet, the greater the volume
of H2O that could be required for resuspension (i.e., add extra H2O in 25 µL increments till the pellet
is resuspended). An aliquot (20 µL) of the suspension was transferred to a clean safety lock Eppendorf
tube (for measurement of protein synthesis), while the remaining 30 µL of the mixture was used for
the analysis of DNA synthesis.
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fractionation/extraction method.
2.4. Analysis of Deuterium Incorporation into Protein
The protein sample (20 µL) was diluted with 400 µL of 6 M HCl and hydrolyzed by incubation at
110 ◦C overnight. Following the acid hydrolysis, the samples were evaporated to complete dryness in
an acid-resistant speed vacuum (Labconco, Kansas, MO, USA) at 60 ◦C. The released amino acids were
derivatized by the addition of pyridine (50 µL, Sigma) and MTBSTFA + 1% TBDMCS (50 µL, Sigma),
and incubated at 60 ◦C for 30 min. The mixture was transferred into 250-µL glass inserts (Agilent) in
2-mL glass vials and analyzed by GC-MS. The 2H incorporation into protein-derived alanine was used
to determine the protein synthesis rates.
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2.5. Analysis of Deuterium Incorporation into DNA
The nucleic acid sample (30 µL) was suspended in 250 µL proteinase K solution (0.2 mg/mL) and
incubated at 55 ◦C overnight. The proteinase K solution was made from a 1-mg/mL H2O stock of
proteinase K (Sigma) mixed with VIAGEN Direct PCR Tail Lysis Reagent (1:4 v/v proteinase K: lysis
buffer). The protein-free solution was diluted with isopropanol (250 µL), and samples were centrifuged
at 20,000× g for 5 min at room temperature, to precipitate DNA. The supernatant was carefully
discarded, the DNA pellet washed with 70% ethanol (500 µL, 2 min) and the supernatant removed after
centrifugation at 20,000× g for 5 min. The DNA pellet was left to dry for ~15 min, then resuspended in
H2O (200 µL) with heating at 55 ◦C for 10 min followed by vortexing. The resuspended DNA samples
were hydrolysed and dephosphorylated by the addition of 50 µL of 5× hydrolysis buffer containing S1
nuclease (Sigma; N5661; 50 kU) and potato acid phosphatase (Merck Millipore/Calbiochem; 524529;
1 kU) and incubated overnight at 37 ◦C [15,35]. The complete (enzyme containing) 5× hydrolysis
buffer was prepared by initially making a 100-mL 5× buffer stock containing 0.375 M of sodium acetate
(pH 5.0; adjusted with glacial acetic acid) and 1 M ZnSO4.7H2O. The potato acid phosphatase was then
resuspended in 1 mL of ultra-pure H2O while the S1 nuclease in 2 mL of 1× hydrolysis buffer (diluted
ZnSO4 containing 5× hydrolysis buffer). Following reconstitution, both enzymes were completely
transferred from their original containers into 37 mL of 5× ZnSO4 containing hydrolysis buffer, making
a final volume of ~40 mL. This complete 5× hydrolysis buffer was aliquoted into Eppendorf tubes
(1 mL each) and stored at −20 ◦C for subsequent use, with each 1-mL aliquot providing ~20 reactions.
After DNA hydrolysis, the deoxyribose moiety was derivatized in a two-step reaction. First, 0.184 M
HCl (100 µL) was added to the 250 µL hydrolysed sample followed by the addition of 10 µL of 50 mM
O-(2,3,4,5,6-pentafluorobenzyl) hydroxylamine hydrochloride (PFHBA, 12.5 mg/mL H2O; Sigma)
and the reaction incubated at 90 ◦C for 3 h. The oxime of deoxyribose was extracted by the addition
of ~20 mg of NaCl (aids biphasic partitioning) and 1 mL of ethyl acetate/hexane mix (1:1 v/v) to
each tube. The samples were vigorously vortexed and centrifuged at 2500× g for 2 min. A portion
(600 µL) of the top organic phase was carefully transferred to a new 12 × 75-mm glass Kimble tube.
A second extraction was then performed on the original sample by the addition of 800 µL of pure ethyl
acetate followed by vortexing and centrifugation, as in the previous step. In the second extraction
750 µL of the top organic phase was carefully transferred to the previously extracted sample in the
corresponding Kimble tube. The pooled samples were then dried in a speed vacuum at 30 ◦C. Once
dry, samples were resuspended in 50 µL of pyridine and 50 µL acetic anhydride (Sigma), thoroughly
vortexed and the mixture transferred into 2-mL GC vials with 250-µL inserts and heated at 60 ◦C for
30 min. This derivatization method forms the perfluorotriacetyl derivative of deoxyribose and permits
analysis via GC-MS in the negative chemical ionization (NCI) mode [35]. Analysis in the NCI mode
increases analytical sensitivity and allows DNA synthesis rates to be performed in the presence of
relatively low yields of DNA [35]. The deuterium incorporation into DNA-derived deoxyribose was
used to quantify DNA synthesis rates and hence cell doubling times [35].
2.6. Analysis of Deuterium Incorporation into Lipids
The dried organic phase (total cellular lipids) was transesterified by the addition of 3N methanolic
HCl (250 µL, Sigma) and incubation at 60 ◦C for 1 h. This reaction releases all esterified fatty acids,
with the formation of the corresponding fatty acid methyl esters (FAME) that are amenable to analysis
by GC-MS. The methanolic HCl was evaporated to dryness under a gentle stream of nitrogen gas and
samples resuspended in pyridine (50 µL) and acetic anhydride (50 µL), vortex mixed and transferred
into 250-µL glass inserts in 2-mL GC vials and heated at 60 ◦C for 30 min. This second reaction
was used to convert lipid-derived glycerol molecules obtained from the transesterification process
into the glycerol triacetate derivative. Total lipid synthesis/turnover rates and de novo lipogenesis
(DNL) were measured by measuring the incorporation of 2H into lipid-derived glycerol and palmitate
(C16:0), respectively. Palmitate labelling is used for DNL measurements, as it is the major product
of the fatty acid synthase reaction in mammals, with labelling in fatty acids that are >16 carbons
in length resulting from chain elongation, not DNL [22,27]. The major advantage of using 2H2O to
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measure DNL is that it accounts for all substrate sources used to make fatty acids (all source DNL),
as opposed to providing a readout of the contribution of only one specific substrate (precursor) to
the newly-synthesized fatty acid, as is the case with other tracers, such as glucose and glutamine,
etc. Note: palmitate contamination is a common occurrence, particularly if plastic consumables are
used with solvents. One should ensure glassware is used where possible and multiple extraction
blanks incorporated into each experiment. The use of multiple extraction blanks can determine the
degree of palmitate contamination. A high palmitate background will lead to an underestimation of
palmitate enrichment in biological samples and may introduce a high variability in labelling between
biological replicates.
2.7. GC-MS
Total protein synthesis/turnover data were generated using an Agilent 6890N GC system and an
Agilent 5975C MSD (Agilent Technologies, Santa Clara, CA, USA) in electron ionization (EI) mode,
with helium as the carrier gas. Specifically the 260 mz (M0), 261 mz (M1) and 262 mz (M2) ions of the
alanine tert-butyldimethylsilyl (t-BDMS) derivative were analyzed in selective ion monitoring mode
(SIM). These specific ions retain the entire molecular structure of the alanine molecule, permitting
every possible deuterium enrichment in the available alanine C-H bonds to be measured. A VF-5
capillary column with a 10-m inert EZ-guard (J & W Scientific, 30 m, 0.25 mm, 0.25 µm) was used,
and the front inlet and transfer line temperatures were both set to 270 ◦C, while the quadrupole and
source temperatures were set to 150 ◦C and 230 ◦C, respectively. The oven temperature gradient was
set to: 100 ◦C (2 min); 100 ◦C–320 ◦C at 25 ◦C/min with a 3-min hold time at 320 ◦C. The sample
(1 µL) was injected with a 20:1 split ratio. Note: for GC-MS tracer isotopic enrichment analysis,
the split ratio setting should be modified accordingly to the intensity of the chromatographic peak,
ensuring that the GC column or MSD are not overloaded (within linear dynamic range) and that the
chromatogram shape is sharp, symmetrical and front or back end tailing not present, as a high quality
chromatographic separation and peak shape are required for accurate tracer enrichment analysis.
Performing an analysis with unlabeled chemical standards over a range of concentrations can easily
determine the dynamic linear range for the specific molecule of interest.
DNA synthesis data were generated using an Agilent 7890B GC system and an Agilent 5977B
MSD in NCI mode, with helium as the carrier and methane as the reagent gas. The perfluorotriacetyl
derivative of deoxyribose was analyzed by monitoring the 435 mz (M0), 436 mz (M1) and 437 mz
(M2) ions in the SIM mode. Note: this derivative results in the formation of two deoxyribose peaks
(cis-, and trans- isomers); typically the larger later eluting peak is used for quantification, although
if chromatogram peaks are of high quality, both should yield near identical enrichments [35]. These
specific ions retain all available deoxyribose C-H bonds [35]. A VF-5 capillary column with a 10-m
inert EZ-guard (J&W Scientific, 30 m, 0.25 mm, 0.25 µm) was used, and the front inlet and transfer
line temperatures were set to 280 ◦C and 250 ◦C, respectively, while the quadrupole and source
temperatures were both set to 150 ◦C. The oven temperature gradient was set to: 50 ◦C (2.25 min);
50 ◦C–320 ◦C at 40 ◦C/min with a 3-min hold time at 320 ◦C. The sample (1 µL) was injected with a 10:1
split ratio. Note: As discussed above for alanine analysis, the split ratio setting should be optimized for
the peak shape and avoidance of overloaded chromatograms. Analysis in the NCI mode is particularly
sensitive, thus high DNA yields will require greater split ratio settings and or sample dilution.
Lipid synthesis data were generated using the same instrument and column as for DNA synthesis;
however, the analysis was performed in positive chemical ionization (PCI) mode. Glycerol triacetate
was analyzed by monitoring the 159 mz (M0), 160 mz (M1) and 161 mz (M2) ions and methyl palmitate
using the 299 mz (M0), 300 mz (M1) and 301 mz (M2) ions. Both glycerol triacetate and methyl palmitate
were analyzed within the one single run in the SIM mode. These specific ions retain all available C-H
bonds within the glycerol and palmitate molecules. The front inlet and transfer line temperatures were
set to 275 ◦C and 250 ◦C, respectively, while the quadrupole and source temperatures were set to 150 ◦C
and 300 ◦C, respectively. The oven temperature gradient was set to: 60 ◦C (1.5 min); 60 ◦C–320 ◦C at
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35 ◦C/min with a 3-min hold time at 320 ◦C. The sample (1 µL) was injected with a 10:1 split ratio.
Again, as discussed earlier, the split ratio should be optimized for each experiment.
2.8. Calculations
The abundance of each chromatographic peak was calculated by integrating the area under the
curve (AUC) for each specific ion using Agilent Mass Hunter Quantitative analysis software. To
calculate sample enrichment, the natural isotopic background abundance of each sample needs to
be subtracted. Therefore, sample enrichment in excess of background enrichment was calculated by
applying the following equation to the calculated AUC values:
EM1 [Excess molar enrichment (%)] = [M1/(M0 + M1)(biologicalsample) − M1/(M0 + M1)(unlabeled sample)] × 100 (1)
The cells not treated with 2H2O served as the reference unlabeled background control samples.
To ensure there was no unexpected ion contamination in the biological samples (matrix effect), an
unlabeled set of chemical standards for each metabolite was measured alongside each run. The natural
isotopic background abundance of each chemical standard was equal to that of the corresponding
unlabeled biological background control, such that:
[M1/(M0 + M1)](unlabeled sample) = [M1/(M0 + M1)](chemical standard) (2)
On the occasion that the percentage of turnover was shown, the calculation was made as follows:
Turnover (%) = EM1(sample)/EM1(max) × 100 (3)
where EM1(max) represents the excess M1 isotopomer enrichment in the fully-labelled (turned over)
metabolite pool, also known as the asymptotic or maximal/plateau value.
To determine the fractional synthesis rate constant (k) and half-life (t1/2) of each specific biomass
pool, rise-to-plateau kinetics were used, whereby non-linear (exponential precursor-product equation)
least squares fitting plots were applied to the enrichment data over time:
F(t)= f(max) × (1 − e−kt); or this can be expressed as EM1(t) = EM1(max) × (1 − e−kt) (4)
where F(t) or EM1(t) represent the fractional or percent 2H enrichment in a specific metabolite (i.e.,
alanine, glycerol, deoxyribose or palmitate) at a specific time during the labelling period (t), f(max)
or EM1(max) represents the asymptotic (maximal or plateau) value in fractional or percentage units
and k is the mathematically-predicted fractional synthesis rate constant (expressed in units of time−1).
In these specific experiments, the culture times were measured in hours; thus, k was expressed as h−1.
Half-life (t1/2) represents the time taken for the specific metabolite pool to be half turned over,
i.e., the time taken to achieve 50% of EM1(max). In the case of DNA synthesis, the t1/2 of enrichment
in DNA-derived deoxyribose represents the cell doubling time, i.e., after one cell division event, two
DNA strands have been duplicated, resulting in two original DNA strands and two new ones (50%
unlabelled and 50% labelled) [35]. Thus, the lower the half-life, the more rapid the rate of synthesis is.
The half-life is calculated by the following equation:
Half-life (t1/2) = 0.693/k (5)
To determine what proportion or percentage of the total esterified palmitate pool was derived
from DNL, it is necessary to perform mass isotopomer distribution analysis (MIDA). MIDA, is a
combinatorial method (binomial distribution model) used to determine the maximum number of
exchangeable carbon bound hydrogens (N) in a specific molecule [16–18,22,23,47]. While beyond a
detailed discussion here, the requirement to perform MIDA on the palmitate data (and many other
lipid classes also) results from the fact that in the presence of 2H2O, the total intracellular palmitate
pool is a combination (mixture) of both labelled ‘self-made’ palmitate molecules and unlabeled
pre-existing (exogenous) ones derived from the serum in the cell culture media. Thus, unlike in the
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other biomass pools analyzed here (i.e., protein-derived alanine, DNA-derived deoxyribose, etc.),
the experimentally-obtained maximal (plateau) 2H enrichment values in palmitate do not necessarily
correspond to the theoretical EM1(max) [16–18,22,23,48]. The experimentally-determined plateau
enrichment values indicate that the DNL-derived palmitate pool is fully turned over (replaced).
However, the specific enrichments have not reached their absolute theoretical maximum as the uptake
and esterification of unlabeled media-derived exogenous palmitate continually dilute the labelled
‘self-made’ pool. To determine the N value and hence true theoretical EM1(max) for labelled palmitate
from the experimental data, one can use the ratio of consecutive isotopomers (M2/M1) and the
enrichment of 2H2O in the culture media (or body water pool in vivo). However, prior to calculating
N, the raw M1 and M2 palmitate isotopomer values obtained from the GC-MS must be corrected
for natural isotopic background abundance skew. Corrections were made using the matrix method
described by Lee et al. [23]. The corrected data are expressed in the mole percent excess (MPE) form,
whereby M0 + M1 + M2 = 100% or 1 if expressed in the fractional form. N was calculated using the
following equation:
M2/M1 = [(N-1)/2]/[media 2H2O enrichment/(1 − media 2H2O enrichment] (6)
Once N was calculated for each experimental time point, the maximal theoretical enrichment,
EM1(max) was calculated as follows:
Theoretical EM1(max) = N × media 2H2O enrichment (7)
Culture media 2H2O enrichment in C2C12 experiments was 4% (0.04), while in colon cancer cell
experiments, it was 5% (0.05).
Finally, with the theoretical EM1(max) solved, the percentage of newly-synthesized palmitate was
then calculated by comparing the experimentally-observed total enrichment at each specific time point
MPEtotal(t) to the theoretical EM1(max), such that:
Newly synthesized palmitate (%) = MPEtotal(t)/theoretical EM1(max) × 100 (8)
MPEtotal(t) =M1 × 1 + M2 × 2 (9)
Given the low amount of 2H2O (precursor) used in this study, M3 enrichments were negligible,
and therefore, only M1 and M2 enrichments were used in the calculation of MPEtotal(t). The MPEtotal(t)
is analogous to a specific activity in radiolabeled tracer terms and represents the observed total number
of 2H atoms incorporated per palmitate molecule at any given experimental time.
3. Results and Discussion
3.1. Establishing a DNA and Protein 2H Labelling Time Course in C2C12 Myoblasts
Experiment 1 validated the biomass fractionation procedure (Figure 1) and the use of 2H2O
labelling combined with the rise to plateau kinetics to simultaneously determine DNA and protein
synthesis rates in rapidly-dividing cells in vitro. The murine C2C12 myoblast line rapidly proliferates
under serum stimulated conditions, but can also be induced to undergo terminal differentiation.
Differentiation is induced by replacing 10% FBS with 2% horse serum (mild serum starvation) when
myoblasts reach confluence, which causes rapidly dividing C2C12 myoblasts to exit the cell cycle and
fuse together to form multinucleated myotubes, a form of immature muscle fiber [48]. To initially
establish the speed at which DNA and protein turnover were occurring under rapidly dividing
conditions (10% FBS), we performed a broad labelling time course whereby subconfluent C2C12
myoblasts were treated with media containing 10% FBS in the presence of 4% 2H2O for a 12–120-h
period. As seen in Figure 2A, 2H enrichment in DNA-derived deoxyribose and protein-derived
alanine occurred rapidly, and while the absolute amount of labelling differed between the two
molecules, the rate of rise in enrichment, referred to as the rise to plateau, was remarkably similar
Metabolites 2016, 6, 34 9 of 19
and occurred within 72 h. Accordingly, using non-linear least squares fitting of plots, the calculated
DNA (k = 0.044 h−1) and protein (0.043 h−1) turnover constants were very similar. The t1/2 for protein,
which represents the time taken to achieve 50% turnover, was 16.16 h. In the case of DNA labelling,
the t1/2, which represents the cell doubling time, was calculated to be 15.69 h, which is consistent
with previously published C2C12 doubling times of 15.2–19.7 h [49], as assessed using manual cell
counting. The maximum level of 2H-labeling in deoxyribose was higher than in alanine (Figure 2A),
because there are more opportunities for 2H to be incorporated into deoxyribose (through the pentose
phosphate pathway, hexose phosphate isomerization) [35], compared to alanine (transamination
of pyruvate) [30–32]. The synthesis rate is therefore determined by empirically measuring the
time taken to achieve the unique maximal (plateau) labelling value, known as the rise to plateau.
The enrichment data in Figure 2A can be rearranged and presented in terms of the relative turnover,
whereby the enrichment at each experimental time point is made relative to the experimental plateau
enrichment value(s) achieved (Figure 2B), resulting in identical k and t1/2 calculations, as in Figure 2A.
Importantly, from a biological perspective, the near identical DNA and protein synthesis rates seen in
rapidly-proliferating C2C12 myoblasts (t1/2 ~16 h) strongly suggests that protein synthesis is largely
driven by cell division. This seems like a logical finding as the stimulation of cell division requires
both DNA and proteome duplication; thus, these two critical processes need to be highly coordinated.
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alanine (A); the percent turnover of the cellular DNA and protein pools over time (B). Inset: fractional
synthesis rate constant (k), half-life (t1/2) and goodness-of-fit (R2) from non-linear curve fitting.
Two replicates were performed for each time point. Error bars represent the standard error of the
mean (SEM).
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3.2. Comparison of Biomass Synthesis Rates under Mitotic and Post-Mitotic Conditions in C2C12 Cells 
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how biomass synthetic rates differ under different growth/physiological conditions. Therefore, we 
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rates were measured in both experiments (Figure 3B: k = 0.047 h−1; t1/2 = 14.77 h vs. Figure 2A:  
k = 0.044 h−1; t1/2 = 15.69), highlighting the high degree of reproducibility between experiments  
(Figures 3 and 4). In contrast, myotubes displayed a dramatic reduction in DNA synthetic rates, with 
no labelling detected in the first 12 h of 2H2O treatment (Figure 3B). This indicates that in the first  
12 h of experimentation, no new cells could be detected in the myotube cultures, while in the 
myoblast cultures ~45% of cells were newly formed. However, when looking across the entire time 
course (Figure 3B), it could be clearly seen that the myotube cultures did display a small degree of 
DNA synthesis, indicating the presence of a minor population of cells that were actively dividing. 
Since the myotube DNA 2H enrichment pattern displayed linear kinetics and was far from reaching 
the plateau (Figure 3B), it was not possible to perform non-linear curve fitting to determine k. 
However, it can be seen that DNA 2H enrichment at the final time point (96 h) in the myotube cultures 
was approximately equal to that seen in the myoblasts at the 12-h time point (Figure 3B), thus 
indicating that on average, myoblast DNA synthesis proceeded ~8-times more rapidly than in the 
myotubes. It is important to note that a large body of literature has shown that when proliferating 
C2C12 myoblast cultures are induced to differentiate through serum withdrawal, a significant 
proportion of these cells escapes terminal differentiation and, thus, does not fuse to form  
myotubes [50–52]. These cells have been referred to as ‘reserve cells’, are thought to be quiescent and 
closely related to satellite stem cells found in skeletal muscle, which are involved in the regeneration 
of adult muscle in vivo [50–52]. Thus, the persistence of DNA synthetic activity, albeit at profoundly 
low rates in the myotube cultures is entirely consistent with the existence of these ‘reserve cells’; 
however, our data suggest that this unique cell population is not quiescent, but rather  
slowly dividing. 
 
Figure 3. Comparison of 2H-incorporation into DNA-derived deoxyribose and protein-derived
alanine in C2C12 myoblasts and myotubes following incubation in 4% 2H2O treatment over 96 h.
Representative images of myoblast and differentiating myotubes (A); excess molar enrichment in the
M1 isotopomer (EM1) over time in DNA-derived deoxyribose (B) and protein-derived alanine (C) in
myoblasts and myotubes. Inset: fractional synthesis rate constant (k), half-life (t1/2) and goodness-of-fit
(R2) from non-linear curve fitting. Two replicates were performed for each time point. Error bars
represent the standard error of the mean (SEM).
3.2. Comparison of Biomass Synthesis Rates under Mitotic and Post-Mitotic Conditions in C2C12 Cells
To further validate the fractionation procedure and analytical methodology, we next determined
how biomass synthetic rates differ under different growth/physiological conditions. Therefore,
we compared 2H2O labelling kinetics in both C2C12 myoblasts and myotubes (Figure 3A). Unlike
myoblasts, which undergo rapid proliferation and accordingly have high biomass synthetic rates,
myotubes are non-dividing. As expected, near identical myoblast DNA synthesis/cell proliferation
rates were measured in both experiments (Figure 3B: k = 0.047 h−1; t1/2 = 14.77 h vs. Figure 2A:
k = 0.044 h−1; t1/2 = 15.69), highlighting the high degree of reproducibility between experiments
(Figures 3 and 4). In contrast, myotubes displayed a dramatic reduction in DNA synthetic rates, with
no labelling detected in the first 12 h of 2H2O treatment (Figure 3B). This indicates that in the first 12 h
of experimentation, no new cells could be detected in the myotube cultures, while in the myoblast
cultures ~45% of cells were newly formed. However, when looking across the entire time course
(Figure 3B), it could be clearly seen that the myotube cultures did display a small degree of DNA
synthesis, indicating the presence of a minor population of cells that were actively dividing. Since
the myotube DNA 2H enrichment pattern displayed linear kinetics and was far from reaching the
plateau (Figure 3B), it was not possible to perform non-linear curve fitting to determine k. However,
it can be seen that DNA 2H enrichment at the final time point (96 h) in the myotube cultures was
approximately equal to that seen in the myoblasts at the 12-h time point (Figure 3B), thus indicating
that on average, myoblast DNA synthesis proceeded ~8-times more rapidly than in the myotubes. It is
important to note that a large body of literature has shown that when proliferating C2C12 myoblast
cultures are induced to differentiate through serum withdrawal, a significant proportion of these cells
escapes terminal differentiation and, thus, does not fuse to form myotubes [50–52]. These cells have
been referred to as ‘reserve cells’, are thought to be quiescent and closely related to satellite stem cells
found in skeletal muscle, which are involved in the regeneration of adult muscle in vivo [50–52]. Thus,
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the persistence of DNA synthetic activity, albeit at profoundly low rates in the myotube cultures is
entirely consistent with the existence of these ‘reserve cells’; however, our data suggest that this unique
cell population is not quiescent, but rather slowly dividing.
We also compared the protein synthetic activity between cultured myoblasts and myotubes.
Rapidly proliferating myoblasts displayed two-fold higher rates of protein synthesis than the myotubes
(Figure 3C: myoblast k = 0.031 h−1, t1/2 = 22.35 h; myotube k = 0.017 h−1; t1/2 = 41.55 h). These data
show that myotubes are metabolically active and continue to actively turn over their proteome despite
being largely post-mitotic.
Simultaneous measurement of 2H labelling in the glycerol and fatty acid moieties of total lipid
extracts provided additional insight into the physiological/metabolic state of myoblasts and myotubes.
2H incorporation into the glycerol backbone of esterified lipids (phospholipids and glycerides) provides
a measure of the rate of synthesis or turnover of the lipid pool, which largely resides in the plasma
and organelle membranes of most cells. As seen in Figure 4A, the labelling kinetics of lipid-derived
glycerol showed that lipid synthesis was more rapid in both myoblasts and myotubes than when
compared to the other biomass components. Specifically, plateau labelling was achieved within the
96-h labelling period in both cell types (Figure 4A). Consistent with their rapid proliferation, myoblast
lipid synthesis occurred almost three-fold more rapidly than in the myotube cultures (Figure 4A:
myoblast k = 0.064 h−1, t1/2 = 10.8 h; myotube k = 0.025 h−1; t1/2 = 28.02 h). These data further
demonstrate that non-dividing C2C12 myotubes are metabolically active and replace the equivalent of
their entire membrane lipid pool every 96 h.
Additionally, analysis of 2H-labelling of total cellular palmitate provides an indication of de novo
lipogenesis (DNL). In myoblasts, 2H-palmitate labelling rapidly reached a plateau after 48 h. In contrast,
2H-labeling in myotubes increased more slowly and had not plateaued over 96 h (Figure 4B).
The calculation of DNL is complicated by the fact that most cells can also take up fatty acids from
the medium (as discussed in the Methods Section), resulting in a lower maximum labelling than
expected if all of the cellular fatty acid needs of the cell were generated by de novo synthesis [22,23].
This can be addressed by performing MIDA to determine experimentally the true theoretical maximum
enrichment in palmitate and, therefore, to determine what portion of palmitate was newly synthesized.
As has been the case in all other biomass components measured, the myoblasts synthesized palmitate
more rapidly than did the myotubes (Figure 4C: myoblast k = 0.026 h−1, t1/2 = 26.43 h; myotube
k = 0.008 h−1; t1/2 = 83.84 h). In the myoblasts, the experimentally-determined maximum (plateau),
also referred to as the equilibrium level of labelling, was ~56% and occurred within 48 h of 2H2O
treatment (Figure 4C). This indicates that ~56% of the total palmitate pool was ‘de novo synthesized’,
and the rest (~44%) was derived from the culture media. Since the 2H enrichment kinetics did not
reach equilibrium levels in the myotubes, we determined the equation predicted maximum value
(Figure 4C; ~77%; R2 = 0.99). Thus, it appears the myotubes were more dependent on the DNL pathway
than the myoblasts, with ~77% of the palmitate being ‘self-made’ and ~23% taken up from media.
These differences may be hardwired into the metabolic networks of each cell type or it could reflect
differences in the fatty acid content of the media. Specifically, myoblasts are grown in serum-rich
medium containing 10% FBS, while myotubes are formed and maintained under serum-deprived
conditions (2% horse serum). Myotubes may therefore be more reliant on the DNL pathway to
supply fatty acids for vital functions, such as membrane synthesis/remodelling. Additionally, having
performed MIDA analysis, we calculated the N values for palmitate under our experimental conditions.
As can be seen in Figure 4D, myoblast and myotube N values did not differ and were remarkably
consistent over the entire experimental time course. Given N was consistent over time, the data
strongly suggest that the precursor pools for palmitate synthesis (H2O, NADPH and acetyl-CoA)
were rapidly labelled and in equilibrium with 2H2O [22,27]. The N values shown in the legend of
Figure 4D are the average of those determined at the 48- and 96-h time points, as these reflect the most
accurate calculations possible due to the high degree of palmitate 2H enrichment at these time points.
Since the calculation of N requires the use of consecutive isotopomer ratios (M2/M1), it is necessary
that sufficient labelling (particularly in the M2 isotopomer) is achieved in the molecule of interest
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in order to attain reliable calculations [47]. The finding that palmitate N values in our C2C12 cells
experiments ranged from 14–15 is similar to that previously reported in the literature in HepG2 and
MCA cancer cells (N = 16–18) [23]. Interestingly, a common feature and advantage of using 2H2O to
label endogenously-synthesized molecules, such as DNA, protein and lipids, lies in the amplification
effect between precursor and product enrichments [16,17,24,30,31,35]. Specifically, the amount of 2H
enrichment (EM1) in various molecules can exceed the 2H2O level, thus enhancing analytical accuracy.
The reason for such an amplification results from the fact that several 2H atoms can incorporate into
the analyte (i.e., multiple C–H bonds within a molecule) [16,17,24,30,31,35]. This is particularly evident
in molecules with a large number of C-H bonds, such as fatty acids, as seen in the myoblast palmitate
data (Figure 4B) where the plateau EM1 values reached ~15.6% while the 2H2O enrichment was only
4%. It is also worthy to mention that the amplification effect appears to be more pronounced in vivo
in animals/humans than in the in vitro cell culture setting, likely due to the existence of additional
pathways for incorporating 2H into product molecules in a multi-organ system [21]. This highlights
the importance of performing rise to plateau experiments (at least initially) in order to establish the
maximal labelling that can be achieved under the specific experimental conditions being performed.
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Figure 4. Comparison of 2H-incorporation into lipid-derived glycerol and total palmitate in C2C12
myoblasts and myotubes following incubation in the presence of 4% 2H2O. Excess molar enrichment in
the M1 isotopomer (EM1) over time in lipid-derived glycerol (A) and total intracellular palmitate (B) in
myoblasts and myotubes. Percentage of n wly-synth sized palmitate in yoblasts and myotubes (C).
The experimental maximum (plateau) v lue represents the percentag of t total i racellular palmitate
pool that was de novo d rived. For myotubes, given that plateau values were not exp rimentally
achieved, this value was equation predicted. The maximum number of exchangeable carbon bound
hydrogens (N) in palmitate as determined using mass isotopomer distribution analysis (MIDA) (D).
Inset: fractional synthesis rate constant (k), half-life (t1/2) and goodness-of-fit (R2) from non-linear
curve fitting. N values seen in the brackets of the legend (D) are an average of those obtained at the 48-
and 96-h time points; these exhibited the greatest amount of labelling and, therefore, permit the most
accurate calculation of N using MIDA. Two replicates were performed for each time point. Error bars
represent the standard error of the mean (SEM).
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3.3. Comparison of Biomass Synthesis Rates in Colon Cancer Cell Lines
Determining the rates at which cells grow and turnover is fundamentally important in cancer
research. Therefore, we wanted to validate our biomass fractionation method to characterize the
growth and turnover characteristics of a panel of human cancer cell lines using 2H2O labelling. We
selected a panel of adherent human colon cancer cell lines; DLD1, SW480, SKCO1 and LOVO [53].
In order to compare the biomass synthesis kinetics of these cells directly to one another, all of the
cell lines were cultured using the same culture media conditions (DMEM in 10% FBS). The 2H
labelling of DNA-derived deoxyribose revealed substantial differences in DNA synthesis rates (k) and
calculated cell doubling times (t1/2) between the various cell lines (Figure 5B). In particular, SW480
cells were found to proliferate almost three-times faster than SKCO1, with the other cells lines having
intermediate replication rates. To validate the cell doubling times obtained using 2H2O labelling and
non-linear curve fitting (t1/2), we additionally performed manual hemocytometer-based cell counting
experiments with the DLD1 and SW480 cell lines grown in the same culture media, but in the absence
of 2H2O. Importantly, manual cell counting yielded near identical cell doubling times to that obtained
using t1/2 values (DLD1: t1/2 ~25.6 h, manual ~24 h; SW480: t1/2 ~19.8 h, manual ~20 h), indicating
that the 2H2O method was accurate and did not have any growth-impeding effects. Interestingly, we
observed a high correlation between the rate of protein synthesis and DNA synthesis across this panel
of cancer cells (Figure 5B,C). For example, similarly to DNA synthesis, SW480 had ~2.5-fold higher
protein synthetic rates than SKCO1. It is worth noting, however, unlike that seen in the proliferating
C2C12 myoblasts, where rates of DNA and protein were similar (Figures 2 and 3), all of the cancer
cell lines displayed higher rates of protein turnover than DNA replication (i.e., lower t1/2 values in
protein compared to that in DNA). This was most evident in the SKCO1 cell line (Figure 5A,B: DNA
t1/2 = 55.7 h; protein t1/2 = 27.7 h; two-fold difference). This indicates that cancer cells may exhibit a
high degree of protein remodelling consistent with enhanced autophagy and proteasome activity [54].
Lipid biosynthesis, as revealed by 2H labelling of lipid-derived glycerol, also reflected overall rates of
cell division, but occurred at a higher rate than DNA replication in these cancer cells (average t1/2 for
DNA across all four lines = 34.4 h; average t1/2 for lipid-glycerol = 11.6 h). Thus, it can be estimated
that on average, during the course of one cell division event, the esterified (stored) lipid pool turned
over three times, indicating a large degree of membrane remodelling. Such rapid lipid turnover was
not evident in the non-malignant C2C12 myoblast cell line (Figures 3A and 4A: DNA t1/2 = 14.8 h;
lipid-glycerol t1/2 = 10.8 h).
As with the C2C12 analysis, we also determined 2H labelling levels and kinetics in the total
intracellular palmitate pool in the colon cancer cell lines. As depicted in Figure 6B,C, 2H enrichment
was rapidly achieved, with plateau (steady) levels occurring within 48 h in all four cell lines. Consistent
with the other biomass components, the most rapidly dividing colon cancer cells displayed the most
rapid palmitate labelling (Figure 6C). Interestingly, there was a pronounced difference in the reliance
on the DNL pathway between the SKCO1 cells and that of the other lines. Specifically, the SKCO1 cells
displayed markedly lower 2H enrichment than the other lines, with ~22% of the cellular palmitate
pool being DNL derived (Figure 6C), whereas DNL contributions were markedly higher in the other
cell lines (Figure 6C: DLD1 ~61%; SW480 ~53%; LOVO ~66%). Furthermore, as with the C2C12
myoblasts and myotubes, upon performing MIDA analysis of palmitate enrichment, N values were
highly stable in each colon cancer cell line over time, indicating rapid and consistent precursor labelling
(Figure 6D). However, the measured palmitate N values in all four colon cancer cell lines (~10 on
average) were substantially lower than that which we had measured in the non-malignant C2C12 cells
(~14.5) or to that found by others in HepG2 and MCA cancer cells (N = 16–18) [23]. This suggests
that the colon cancer lines display a reduction in hydrogen atom exchange rates between cellular
H2O and the NADPH and/or acetyl-CoA precursor pools. The reason for this remains unclear. It is
worthy to mention that our findings of varied reliance on the DNL pathway between different colon
cancer cell lines in vitro do not support the commonly accepted notion in the literature that cancer
cells (and proliferating cells in general) are predominantly dependent on the de novo synthesis of
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fatty acids [55–57]. It is clear from our data that in the colon cancer cell lines and also in the rapidly
proliferating C2C12 myoblasts that quantitatively significant amounts of the stored (esterified) fatty
acid pool was serum and not de novo derived. In fact, in the case of the SKCO1 cancer cell line,
the vast majority (~78%) of intracellular palmitate was exogenously derived. This capacity to use
exogenous extracellular fatty acids for complex lipid synthesis has also been recently demonstrated
by others in a range of rapidly dividing cell lines in vitro [58]. Conversely, in our predominantly
non-dividing C2C12 myotube cultures, the reliance on the DNL pathway was relatively high (~77%
palmitate was ‘self-made’), thus indicating the reliance on the DNL pathway is unlikely related to
cell proliferation. The 2H2O labelling technique and extraction method described here could easily
be applied to 3D culture systems and is also ideally suited for studying in vivo tumor growth and
metabolism in pre-clinical animal models [59,60] and human clinical settings [36,61].
Metabolites 2016, 6, 34 14 of 19 
cancer cells (N = 16–18) [23]. This suggests that the colon cancer lines display a reduction in hydrogen 
atom exchange rates between cellular H2O and the NADPH and/or acetyl-CoA precursor pools. The 
reason for this remains unclear. It is worthy to mention that our findings of varied reliance on the 
DNL pathway between different colon cancer cell lines in vitro do not support the commonly 
accepted notion in the literature that cancer cells (and proliferating cells in general) are 
predominantly dependent on the de novo synthesis of fatty acids [55–57]. It is clear from our data 
that in the colon cancer cell lines and also in the rapidly proliferating C2C12 myoblasts that 
quantitatively significant amounts of the stored (esterified) fatty acid pool was serum and not de 
novo derived. In fact, in the case of the SKCO1 cancer cell line, the vast majority (~78%) of intracellular 
palmitate was exogenously derived. This capacity to use exogenous extracellular fatty acids for 
complex lipid synthesis has also been recently demonstrated by others in a range of rapidly dividing 
cell lines in vitro [58]. Conversely, in our predominantly non-dividing C2C12 myotube cultures, the 
reliance on the DNL pathway was relatively high (~77% palmitate was ‘self-made’), thus indicating 
the reliance on the DNL pathway is unlikely related to cell proliferation. The 2H2O labelling technique 
and extraction method described here could easily be applied to 3D culture systems and is also ideally 
suited for studying in vivo tumor growth and metabolism in pre-clinical animal models [59,60] and 
human clinical settings [36,61]. 
 
Figure 5. Comparison of 2H-incorporation into DNA-bound deoxyribose and protein-derived alanine 
in colon cancer cell lines following incubation in the presence of 5% 2H2O over 96 h. Representative 
images of colon cancer cell lines (A). Excess molar enrichment in the M1 isotopomer (EM1) over time 
in DNA-derived deoxyribose (B) and protein-derived alanine (C) in human colon cancer cell lines 
grown under identical conditions. Inset: fractional synthesis rate constant (k), half-life (t1/2) and 
goodness-of-fit (R2) from non-linear curve fitting. Three replicates were performed for each time 
point. Error bars represent the standard error of the mean (SEM). 
Figure 5. Comparison of 2H-incorporation into DNA-bound deoxyribose and protein-derived alanine
in colon cancer cell lines following incubation in the presence of 5% 2H2O over 96 h. Representative
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cells, compared to DNA and protein, it is the lipid pools that undergo the most rapid turnover. 
Finally, our data reveal a marked heterogeneity in the reliance on the DNL pathway in a panel of 
different human colon cancer cell lines. 
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-1989/6/4/34/s1. 
Acknowledgments: This work was supported by the following grants: Diabetes Australia Research Trust 
(G.M.K.) and the Ludwig Institute for Cancer Research, and the Victorian Government’s Operational 
Infrastructure Support Program (O.M.S.). M.J.M. is an NHMRC Principal Research Fellow (APP1059530). G.M.K. 
is supported by an Alfred Deakin Post-Doctoral Fellowship (Deakin University). O.M.S. is an NHMRC R.D. 
Figure 6. Comparison of 2H-incorporation into lipid-derived glycerol and total palmitate in colon
cancer cell lines following incubation in 5% 2H2O for 96 h. Excess molar enrichment in the M1
isotopomer (EM1) over time in lipid-derived glycerol (A) and total intracellular palmitate (B) in human
colon cancer cell lines grown under identical conditions. Percentage of newly-synthesized palmitate in
colon cancer cell lines (C). The experimental maximum (plateau) value represents the percentage of the
total intracellular palmitate pool that was de novo derived. The maximum number of exchangeable
carbon bound hydrogens (N) in palmitate as determined using MIDA (D). Inset: fractional synthesis
rate constant (k), half-life (t1/2) and goodness-of-fit (R2) from non-linear curve fitting. N values seen
in the brackets of the legend (D) are an average of those obtained at the 48-, 72- and 96-h time points;
these exhibited the greatest amount of labelling and, therefore, permit the most accurate calculation of
N using MIDA. Three replicates were performed for each time point. Error bars represent the standard
error of the mean (SEM).
4. Conclusions
Taken together, we present here a cell fractionation/extraction method to combine with 2H2O
labelling and GC-MS analysis in order to simultaneously measure different cellular biomass synthesis
rates from the one sample. Using this method, we were able to validate that in actively-proliferating
mammalian cells, biomass synthesis rates are strongly linked to the rate of cell division, thus
demonstrating the utility of the approach. Furthermore, in both proliferating and non-proliferating
cells, compared to DNA and protein, it is the lipid pools that undergo the most rapid turnover. Finally,
our data reveal a marked heterogeneity in the reliance on the DNL pathway in a panel of different
human colon cancer cell lines.
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